Heat Biologics: Rises on collaboration for coronavirus vaccine development

Scorpius Holdings

05/03/2020 19:17

** Shares of vaccine developer  HTBX.O  rise ~34% to $1.10 
    ** Co to collaborate with University of Miami Miller School
of Medicine to develop coronavirus vaccine [https://bit.ly/2TsST6d
]
    ** Under terms of research collaboration, the university
will develop and test one or more vaccine constructs utilizing
HTBX's gp-96 vaccine platform [https://bit.ly/2TsST6d
]
    ** Shares jumped as much as ~142% on March 2 when co filed
provisional patent application that applies its immune system
activating technology for treating or preventing coronavirus
infection [http://bit.ly/2VzjcJr
]
    ** Including session's gain, shares rose ~134% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))